English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47 Journal article
Shan, Wenying, Chen, Lvqi, Xu, Hao, Zhong, Qinghao, Xu, Yinqiu, Yao, Hequan, Lin, Kejiang, Li, Xuanyi. GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47[J]. Frontiers in Chemistry, 2023, 11.
Authors:  Shan, Wenying;  Chen, Lvqi;  Xu, Hao;  Zhong, Qinghao;  Xu, Yinqiu; et al.
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:3.8/4.8 | Submit date：2024/02/22
Artificial Intelligence  Compound-protein Interaction Prediction  Gcforest  Small-molecule Cd47 Inhibitors  Word2vec  
Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics Journal article
Zhang W., Hu X., Chakravarty H., Yang Z., Tam K.Y.. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics[J]. ACS Combinatorial Science, 2018, 20(11), 660-671.
Authors:  Zhang W.;  Hu X.;  Chakravarty H.;  Yang Z.;  Tam K.Y.
Favorite | TC[WOS]:12 TC[Scopus]:12 | Submit date：2018/12/18
Cancer  High-throughput Screening  Pyruvate Dehydrogenase Kinase 1  Small Molecule Inhibitors  Warburg Effect  
Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics Journal article
Zhang, W., Hu, X., Chakravarty, H., Yang, Z., Tam, K. Y.. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics[J]. ACS Combinatoral Science, 2018, 660-671.
Authors:  Zhang, W.;  Hu, X.;  Chakravarty, H.;  Yang, Z.;  Tam, K. Y.
Favorite | TC[WOS]:12 TC[Scopus]:12  IF:3.903/3.637 | Submit date：2022/07/28
Cancer  Warburg Effect  High-throughput Screening  Pyruvate Dehydrogenase Kinase 1  Small Molecule Inhibitors  
The p38 MAPK inhibitor SB203580 abrogates TNF-mediated expansion of regulatory T cells Conference paper
Chen, X., He, T.Zh.. The p38 MAPK inhibitor SB203580 abrogates TNF-mediated expansion of regulatory T cells[C], 2017.
Authors:  Chen, X.;  He, T.Zh.
Favorite |  | Submit date：2022/08/30
SB203580  small molecule inhibitors  TNFR2  Tregs